Creative Capital Management Investments’s AbbVie ABBV Stock Holding History

Creative Capital Management Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Buy	1,492 +31	+2%	+$6.67K	0.09%	52
2026 Q1	$318K	Hold	1,461	–	–	0.09%	40
2025 Q4	$334K	Hold	1,461	–	–	0.1%	38
2025 Q3	$338K	Sell	1,461 -35	-2%	-$7.13K	0.11%	37
2025 Q2	$278K	Buy	1,496 +35	+2%	+$6.5K	0.1%	39
2025 Q1	$306K	Hold	1,461	–	–	0.12%	39
2024 Q4	$260K	Buy	1,461 +130	+10%	+$23.9K	0.11%	41
2024 Q3	$263K	Hold	1,331	–	–	0.11%	43
2024 Q2	$228K	Hold	1,331	–	–	0.11%	40
2024 Q1	$242K	Hold	1,331	–	–	0.13%	37
2023 Q4	$206K	Hold	1,331	–	–	0.12%	39
2023 Q3	$198K	Hold	1,331	–	–	0.14%	37
2023 Q2	$179K	Hold	1,331	–	–	0.13%	41
2023 Q1	$212K	Buy	1,331 +3	+0.2%	+$459	0.16%	44
2022 Q4	$215K	Buy	+1,328	New	+$204K	0.19%	38

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Creative Capital Management Investments's ABBV Position: Q2 2026 in Review

Creative Capital Management Investments increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $6.67K and bringing the position to 1,492 shares worth $375K. The position accounts for 0.09% of the portfolio, ranked #52.

Creative Capital Management Investments first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Creative Capital Management Investments held 1,492 shares of AbbVie worth $375K as of Q2 2026.
Creative Capital Management Investments bought 31 AbbVie shares in Q2 2026, an estimated $6.67K.
AbbVie made up 0.09% of Creative Capital Management Investments's portfolio in Q2 2026, its #52 holding.
Creative Capital Management Investments first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.